Response of the cerebral vasculature following traumatic brain injury

A Salehi, JH Zhang, A Obenaus - Journal of Cerebral Blood …, 2017 - journals.sagepub.com
The critical role of the vasculature and its repair in neurological disease states is beginning
to emerge particularly for stroke, dementia, epilepsy, Parkinson's disease, tumors and …

Cell-free DNA-based liquid biopsies in neurology

H Gaitsch, RJM Franklin, DS Reich - Brain, 2023 - academic.oup.com
This article reviews recent developments in the application of cell-free DNA-based liquid
biopsies to neurological diseases. Over the past few decades, an explosion of interest in the …

[HTML][HTML] Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a …

T CRASH - The Lancet, 2019 - Elsevier
Background Tranexamic acid reduces surgical bleeding and decreases mortality in patients
with traumatic extracranial bleeding. Intracranial bleeding is common after traumatic brain …

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized …

H Shakur, I Roberts - 50 Landmark Papers every Trauma …, 2019 - api.taylorfrancis.com
This important paper addressed a key clinical question, which was exceptionally novel at the
time of investigation. Namely, could the early administration of 1 gram of tranexamic acid …

Association between prehospital tranexamic acid administration and outcomes of severe traumatic brain injury

SM Bossers, SA Loer, FW Bloemers… - Jama …, 2021 - jamanetwork.com
Importance The development and expansion of intracranial hematoma are associated with
adverse outcomes. Use of tranexamic acid might limit intracranial hematoma formation, but …

CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

Y Dewan, EO Komolafe, JH Mejía-Mantilla, P Perel… - Trials, 2012 - Springer
Background Worldwide, over 10 million people are killed or hospitalized because of
traumatic brain injury each year. About 90% of deaths occur in low-and middle-income …

Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial

S Yutthakasemsunt, W Kittiwatanagul… - BMC emergency …, 2013 - Springer
Background Traumatic brain injury (TBI) is commonly accompanied by intracranial bleeding
which can worsen after hospital admission. Tranexamic acid (TXA) has been shown to …

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury …

P Perel, R Al-Shahi Salman… - Health technology …, 2012 - researchonline.lshtm.ac.uk
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …

[HTML][HTML] Angiogenic peptide hydrogels for treatment of traumatic brain injury

X Ma, A Agas, Z Siddiqui, KK Kim, P Iglesias-Montoro… - Bioactive Materials, 2020 - Elsevier
Traumatic brain injury (TBI) impacts over 3.17 million Americans. Management of
hemorrhage and coagulation caused by vascular disruption after TBI is critical for the …

Neuroimaging and neuropathology of TBI

ED Bigler, WL Maxwell - NeuroRehabilitation, 2011 - content.iospress.com
Neuroimaging at all stages of a traumatic brain injury (TBI) provides information about gross
brain pathology. In this review, post-mortem TBI cases are matched to neuroimaging …